SF3B1 and cancer: While splicing changes are highly context dependent and vary across cell lines and cancer types, work intersecting human and mouse model systems containing SF3B1 mutations have found two SF3B1 mis-spliced target mRNAs that are highly conserved: MAP3K7 and PPP2R5A (Liu et al., 2020, 2021).